Founded by two Montreal pharmacists. Research & Development (R&D) activities began with 5 employees.
Acquisition and workplace planning of drug production facility in Montreal.
Establishment of an Eastern European Business Office in Kiev, Ukraine.
Investment of CAD$3 million in the creation of modern research laboratories of a pilot production plant in Montreal.
Investment of CAD$8 million in the acquisition of a building to set up the head office, an administrative business headquarters and an operational facility in Montreal.
Investment of CAD$3 million for the construction of an ultra-modern distribution centre, near the head office in Montreal.
Establishment of a government partnership (Investissement Québec and Emploi-Québec).
Investment of CAD$150 million in a major expansion project.
Investment of CAD$12 million to acquire Pangeo, a Quebec pharmaceutical company, and to hire approximately 125 employees.
Opened a representative office in Vietnam.
Pharmascience celebrates its 25th year of operations.
Investment close to CAD$40 million: Inauguration of new facilities in Montreal and creation of 180 jobs.
Acquisition of Aegera Therapeutics, a Montreal-based clinical-stage biotechnology company.
Class A Certification – Operational Excellence. This certification is an independent rating by world-class supply chain consultants. Pharmascience is the #1 customer service company in the pharmaceutical industry (for both branded and generic products) and is able to fill the orders of all customers routinely over 98% of the time. This sought after classification is achieved by only 5% of companies in Canada.
Acquisition of Uman Pharma Inc., a fully-integrated company that develops, manufactures and markets generic injectable pharmaceutical products.